Novo Nordisk Appoints Mehtaz Sultan Khan to Lead Pakistan Operations
Mehtaz Sultan Khan takes charge as Novo Nordisk's General Manager for Pakistan.
Novo Nordisk has appointed Mehtaz Sultan Khan as its new General Manager for Pakistan, effective August 3, 2026, as the global healthcare company strengthens its presence in the country’s diabetes and obesity care market.
Business Opportunity Conference to Boost Pakistan-Türkiye Trade Ties, ICCI Announces
The appointment comes at a significant time for the company following the launch of its innovative obesity therapy in Pakistan and its ongoing efforts to improve access to treatment for people living with chronic diseases. Novo Nordisk said the leadership change supports its long-term commitment to expanding healthcare solutions and patient access across the country.
More than 100 words into the article – Novo Nordisk said Mehtaz Sultan Khan brings more than 15 years of leadership experience across the healthcare and consumer goods sectors. During his career, he has led commercial strategy, business transformation and brand development in Pakistan, Saudi Arabia, the Gulf region and Iraq, building extensive regional expertise.
Extensive Leadership Experience
Before joining Novo Nordisk, Mehtaz served as Marketing Director at Abbott Nutrition International for Pakistan and Iraq.
He also held senior leadership positions at Reckitt, Nestlé, Almarai and Shan Foods, where he contributed to commercial growth, marketing strategy and organisational development across multiple regional markets.
Focus on Expanding Patient Access
Commenting on his appointment, Mehtaz Sultan Khan said he looks forward to working closely with the company’s team and healthcare stakeholders to improve access to treatment, increase disease awareness and create sustainable value for patients in Pakistan.
He said Novo Nordisk remains committed to supporting better healthcare outcomes through innovation and stronger partnerships.
Company Sees Growth Opportunities
Burak Cem, Vice President for BAMECA, welcomed the appointment and said Mehtaz’s leadership experience would support the company’s next phase of growth in Pakistan.
He added that Novo Nordisk aims to strengthen partnerships with healthcare stakeholders while expanding access to innovative therapies for patients living with chronic conditions.
The appointment reflects Novo Nordisk’s continued investment in Pakistan’s healthcare sector as demand for advanced diabetes and obesity treatments continues to grow.
